Reporting of potential immunogenicity with biologic drugs: Clarity and accuracy required

Robert J. Moots, Alejandro Balsa, Gertjan Wolbink

Research output: Contribution to journal › Comment/Letter to the editor › Academic

10 Citations (Scopus)

Original language	English
Pages (from-to)	e24
Journal	Annals of the rheumatic diseases
Volume	75
Issue number	5
DOIs	https://doi.org/10.1136/annrheumdis-2016-209178
Publication status	Published - May 2016

Access to Document

@article{81ed819b8818447e9a1b5b526c24dce4,

title = "Reporting of potential immunogenicity with biologic drugs: Clarity and accuracy required",

author = "Moots, {Robert J.} and Alejandro Balsa and Gertjan Wolbink",

year = "2016",

month = may,

doi = "https://doi.org/10.1136/annrheumdis-2016-209178",

language = "English",

volume = "75",

pages = "e24",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "5",

}

TY - JOUR

T1 - Reporting of potential immunogenicity with biologic drugs

T2 - Clarity and accuracy required

AU - Moots, Robert J.

AU - Balsa, Alejandro

AU - Wolbink, Gertjan

PY - 2016/5

Y1 - 2016/5

UR - http://www.scopus.com/inward/record.url?scp=84958073489&partnerID=8YFLogxK

U2 - https://doi.org/10.1136/annrheumdis-2016-209178

DO - https://doi.org/10.1136/annrheumdis-2016-209178

M3 - Comment/Letter to the editor

C2 - 26847822

SN - 0003-4967

VL - 75

SP - e24

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 5

ER -